Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
InflaRx N.V.
InflaRx to Report First Quarter 2026 Results on May 7, 2026
May 1, 2026
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
April 28, 2026
InflaRx Reports New Mechanistic Data for Izicopan Supporting its Potential as a Best-in-Class C5aR Inhibitor
April 9, 2026
InflaRx Announces Participation in the Raymond James 2026 Biotech Innovation Symposium
March 31, 2026
InflaRx Reports Full Year 2025 Results and Highlights Key Achievements and Expected Milestones
March 19, 2026
InflaRx to Report Full Year 2025 Results on March 19, 2026
March 12, 2026
←
Previous Page
1
2